Press Releases from DelveInsight Business Research LLP (4878 total)
Triple Refractory Multiple Myeloma Therapeutics Market Size in 7MM is expected t …
DelveInsight's "Triple Refractory Multiple Myeloma Market Insights, Epidemiology, and Market Forecast-2032" Report delivers an in-depth understanding of the Triple Refractory Multiple Myeloma, historical and forecasted…
Pediatric Brain Tumors Therapeutics Market Size in 7MM is expected to grow at a …
DelveInsight's "Pediatric Brain Tumors Market Insights, Epidemiology, and Market Forecast-2034" Report delivers an in-depth understanding of the Pediatric Brain Tumors, historical and forecasted epidemiology as…
Mucosa-associated Lymphoid Tissue (MALT) Lymphoma Therapeutics Market Size in 7M …
DelveInsight's "Mucosa-associated Lymphoid Tissue (MALT) Lymphoma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Mucosa-associated Lymphoid Tissue (MALT) Lymphoma, historical…
Bowen's Disease Therapeutics Market Size in 7MM is expected to grow at a decent …
DelveInsight's "Bowen's Disease Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Bowen's Disease, historical and forecasted epidemiology as well as…
Parkinson's Disease Pipeline Analysis and Clinical Trials Assessment, 2025 by De …
Parkinson's Disease Pipeline constitutes 130+ key companies continuously working towards developing 150+ Parkinson's Disease treatment therapies, analyzes DelveInsight.
Parkinson's Disease Overview:
Parkinson's disease (PD) is a long-term,…
Ocular Hypertension Pipeline Analysis and Clinical Trials Assessment, 2025 by De …
Ocular Hypertension Pipeline constitutes 50+ key companies continuously working towards developing 75+ Ocular Hypertension treatment therapies, analyzes DelveInsight.
Ocular Hypertension Overview:
Ocular hypertension refers to a condition…
Chronic Lymphocytic Leukemia Pipeline Analysis and Clinical Trials Assessment, 2 …
Chronic Lymphocytic Leukemia Pipeline constitutes 55+ key companies continuously working towards developing 60+ Chronic Lymphocytic Leukemia treatment therapies, analyzes DelveInsight.
Chronic Lymphocytic Leukemia Overview:
Chronic lymphocytic leukemia…
Nephrotic Syndrome Pipeline Analysis and Clinical Trials Assessment, 2025 by Del …
Nephrotic Syndrome Pipeline constitutes 3+ key companies continuously working towards developing 3+ Nephrotic Syndrome treatment therapies, analyzes DelveInsight.
Nephrotic Syndrome Overview:
**Nephrotic Syndrome** is a collection of…
Netherton Syndrome Pipeline Analysis and Clinical Trials Assessment, 2025 by Del …
Netherton Syndrome Pipeline constitutes 5+ key companies continuously working towards developing 5+ Netherton Syndrome treatment therapies, analyzes DelveInsight.
Netherton Syndrome Overview:
**Netherton Syndrome (NS)** is a rare…
Opioid Withdrawal Syndrome Pipeline Analysis and Clinical Trials Assessment, 202 …
Opioid Withdrawal Syndrome Pipeline constitutes 4+ key companies continuously working towards developing 4+ Opioid Withdrawal Syndrome treatment therapies, analyzes DelveInsight.
Opioid Withdrawal Syndrome Overview:
Opioid Withdrawal Syndrome…
Parainfluenza Virus Infection Pipeline Analysis and Clinical Trials Assessment, …
Parainfluenza Virus Infection Pipeline constitutes 5+ key companies continuously working towards developing 5+ Parainfluenza Virus Infection treatment therapies, analyzes DelveInsight.
Parainfluenza Virus Infection Overview:
The human parainfluenza…
Multiple sclerosis Pipeline Analysis and Clinical Trials Assessment, 2025 by Del …
Multiple sclerosis Pipeline constitutes 75+ key companies continuously working towards developing 80+ Multiple sclerosis treatment therapies, analyzes DelveInsight.
Multiple sclerosis Overview:
Multiple sclerosis (MS) is the most…
Myelodysplastic Syndrome Pipeline Analysis and Clinical Trials Assessment, 2025 …
Myelodysplastic Syndrome Pipeline constitutes 120+ key companies continuously working towards developing 125+ Myelodysplastic Syndrome treatment therapies, analyzes DelveInsight.
Myelodysplastic Syndrome Overview:
Myelodysplastic syndrome (MDS) is a diverse…
Natural Killer Cell Therapies Pipeline Analysis and Clinical Trials Assessment, …
Natural Killer Cell Therapies Pipeline constitutes 100+ key companies continuously working towards developing 140+ Natural Killer Cell Therapies treatment therapies, analyzes DelveInsight.
Natural Killer Cell Therapies…
Obstructive Sleep Apnea Pipeline Analysis and Clinical Trials Assessment, 2025 b …
Obstructive Sleep Apnea Pipeline constitutes 20+ key companies continuously working towards developing 21+ Obstructive Sleep Apnea treatment therapies, analyzes DelveInsight.
Obstructive Sleep Apnea Overview:
Obstructive Sleep Apnea…
Nontuberculous Mycobacterial Infections Pipeline Analysis and Clinical Trials As …
Nontuberculous Mycobacterial Infections Pipeline constitutes 10+ key companies continuously working towards developing 10+ Nontuberculous Mycobacterial Infections treatment therapies, analyzes DelveInsight.
Nontuberculous Mycobacterial Infections Overview:
Nontuberculous Mycobacterial (NTM)…
Myotonic Dystrophy Pipeline Analysis and Clinical Trials Assessment, 2025 by Del …
Myotonic Dystrophy Pipeline constitutes 20+ key companies continuously working towards developing 22+ Myotonic Dystrophy treatment therapies, analyzes DelveInsight.
Myotonic Dystrophy Overview:
Myotonic Dystrophy (DM) is the most…
Food Allergy Pipeline Analysis and Clinical Trials Assessment, 2025 by DelveInsi …
Food Allergy Pipeline constitutes 25+ key companies continuously working towards developing 30+ Food Allergy treatment therapies, analyzes DelveInsight.
Food Allergy Overview:
Food allergies are harmful immune responses…
Smoking Cessation and Nicotine Addiction Pipeline Analysis and Clinical Trials A …
Smoking Cessation and Nicotine Addiction Pipeline constitutes 5+ key companies continuously working towards developing 5+ Smoking Cessation and Nicotine Addiction treatment therapies, analyzes DelveInsight.
Smoking Cessation…
Sepsis Pipeline Analysis and Clinical Trials Assessment, 2025 by DelveInsight | …
Sepsis Pipeline constitutes 25+ key companies continuously working towards developing 30+ Sepsis treatment therapies, analyzes DelveInsight.
Sepsis Overview:
Sepsis is a critical and potentially fatal condition that…
Focal Segmental Glomerulosclerosis Pipeline Analysis and Clinical Trials Assessm …
Focal Segmental Glomerulosclerosis Pipeline constitutes 15+ key companies continuously working towards developing 18+ Focal Segmental Glomerulosclerosis treatment therapies, analyzes DelveInsight.
Focal Segmental Glomerulosclerosis Overview:
Focal Segmental Glomerulosclerosis…
Janus Kinase (JAK) Inhibitor Pipeline Analysis and Clinical Trials Assessment, 2 …
Janus Kinase (JAK) Inhibitor Pipeline constitutes 50+ key companies continuously working towards developing 55+ Janus Kinase (JAK) Inhibitor treatment therapies, analyzes DelveInsight.
Janus Kinase (JAK) Inhibitor…
Gastrointestinal Stromal Tumors (GIST) Pipeline Analysis and Clinical Trials Ass …
Gastrointestinal Stromal Tumors (GIST) Pipeline constitutes 25+ key companies continuously working towards developing 28+ Gastrointestinal Stromal Tumors (GIST) treatment therapies, analyzes DelveInsight.
Gastrointestinal Stromal Tumors (GIST)…
Glioblastoma Pipeline Analysis and Clinical Trials Assessment, 2025 by DelveInsi …
Glioblastoma Pipeline constitutes 180+ key companies continuously working towards developing 200+ Glioblastoma treatment therapies, analyzes DelveInsight.
Glioblastoma Overview:
Glioblastoma Multiforme (GBM) is the most common and aggressive…
Systemic Lupus Erythematosus Clinical and Non-Clinical Studies, Key Companies, T …
Systemic Lupus Erythematosus Pipeline constitutes 120+ key companies continuously working towards developing 140+ Systemic Lupus Erythematosus treatment therapies, analyzes DelveInsight.
Systemic Lupus Erythematosus Overview:
Systemic Lupus Erythematosus…
Wet Age-Related Macular Degeneration (Wet-AMD) Clinical and Non-Clinical Studies …
Wet Age-Related Macular Degeneration (Wet-AMD) Pipeline constitutes 60+ key companies continuously working towards developing 70+ Wet Age-Related Macular Degeneration (Wet-AMD) treatment therapies, analyzes DelveInsight.
Wet Age-Related…
Liver Cirrhosis Clinical and Non-Clinical Studies, Key Companies, Therapeutic As …
Liver Cirrhosis Pipeline constitutes 30+ key companies continuously working towards developing 30+ Liver Cirrhosis treatment therapies, analyzes DelveInsight.
Liver Cirrhosis Overview:
Liver cirrhosis is a chronic condition…
Malignant Ascites Clinical and Non-Clinical Studies, Key Companies, Therapeutic …
Malignant Ascites Pipeline constitutes 5+ key companies continuously working towards developing 5+ Malignant Ascites treatment therapies, analyzes DelveInsight.
Malignant Ascites Overview:
Ascites refers to the accumulation of…
Pancreatic Endocrine Tumor Treatment Market Size in 7MM is expected to grow at a …
DelveInsight's "Pancreatic Endocrine Tumor Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Pancreatic Endocrine Tumor, historical and forecasted epidemiology as…
Papilloma Treatment Market Size in 7MM is expected to grow at a decent CAGR by 2 …
DelveInsight's "Papilloma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Papilloma, historical and forecasted epidemiology as well as the Papilloma…
Paraganglioma Treatment Market Size in 7MM is expected to grow at a decent CAGR …
DelveInsight's "Paraganglioma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Paraganglioma, historical and forecasted epidemiology as well as the Paraganglioma…
Pediatric Central Nervous System Tumors Treatment Market Size in 7MM is expected …
DelveInsight's "Pediatric Central Nervous System Tumors Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Pediatric Central Nervous System Tumors, historical…
Pediatric Neuroblastoma Treatment Market Size in 7MM is expected to grow at a de …
DelveInsight's "Pediatric Neuroblastoma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Pediatric Neuroblastoma, historical and forecasted epidemiology as well as…
Iron Deficiency Anemia Treatment Market Size in 7MM is expected to grow at a dec …
DelveInsight's "Iron Deficiency Anemia Market Insights, Epidemiology, and Market Forecast-2034" report offers an in-depth understanding of the Iron Deficiency Anemia, historical and forecasted epidemiology as…
Hypofibrinogenemia Treatment Market Size in 7MM is expected to grow at a decent …
DelveInsight's "Hypofibrinogenemia Market Insights, Epidemiology and Market Forecast - 2034" report delivers an in-depth understanding of Hypofibrinogenemia, historical and forecasted epidemiology as well as the…
Fibrodysplasia Ossificans Progressiva Treatment Market Size in 7MM is expected t …
DelveInsight's "Fibrodysplasia Ossificans Progressiva Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Fibrodysplasia Ossificans Progressiva, historical and forecasted epidemiology as…
Fecal Incontinence Treatment Market Size in 7MM is expected to grow at a decent …
DelveInsight's "Fecal Incontinence Market Insight, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the fecal incontinence historical and forecasted epidemiology as…
Fanconi Anemia Treatment Market Size in 7MM is expected to grow at a decent CAGR …
DelveInsight's "Fanconi Anemia Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Fanconi Anemia, historical and forecasted epidemiology as well as…
Presbyopia Treatment Market Size in 7MM is expected to grow at a decent CAGR by …
DelveInsight's "Presbyopia Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of presbyopia, historical and forecasted epidemiology as well as the…
Systemic Lupus Erythematosus Treatment Market Size in 7MM is expected to grow at …
DelveInsight's "Systemic Lupus Erythematosus Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of the Systemic Lupus Erythematosus, historical and forecasted epidemiology as…
Intermediate AMD Treatment Market Size in 7MM is expected to grow at a decent CA …
DelveInsight's "Intermediate AMD Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of intermediate AMD, historical and forecasted epidemiology as well…
ESR1 Mutated Metastatic Breast Cancer Treatment Market Size in 7MM is expected t …
DelveInsight's "ESR1-mutated Metastatic Breast Cancer Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology…
Malignant Ascites Treatment Market Size in 7MM is expected to grow at a decent C …
DelveInsight's "Malignant Ascites Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Malignant Ascites, historical and forecasted epidemiology as well as…
Primary Biliary Cholangitis Clinical and Non-Clinical Studies, Key Companies, Th …
Primary Biliary Cholangitis Pipeline constitutes 20+ key companies continuously working towards developing 25+ Primary Biliary Cholangitis treatment therapies, analyzes DelveInsight.
Primary Biliary Cholangitis Overview:
Primary Biliary Cholangitis…
Primary Hyperoxaluria Clinical and Non-Clinical Studies, Key Companies, Therapeu …
Primary Hyperoxaluria Pipeline constitutes 6+ key companies continuously working towards developing 6+ Primary Hyperoxaluria treatment therapies, analyzes DelveInsight.
Primary Hyperoxaluria Overview:
Primary hyperoxaluria type 1 (PH1) is…
Stargardt Disease Clinical and Non-Clinical Studies, Key Companies, Therapeutic …
Stargardt Disease Pipeline constitutes 20+ key companies continuously working towards developing 20+ Stargardt Disease treatment therapies, analyzes DelveInsight.
Stargardt Disease Overview:
Stargardt disease is a genetic disorder…
Stress urinary incontinence Clinical and Non-Clinical Studies, Key Companies, Th …
Stress urinary incontinence Pipeline constitutes 10+ key companies continuously working towards developing 10+ Stress urinary incontinence treatment therapies, analyzes DelveInsight.
Stress urinary incontinence Overview:
Stress Urinary Incontinence…
Surgical Site Infections Clinical and Non-Clinical Studies, Key Companies, Thera …
Surgical Site Infections Pipeline constitutes 5+ key companies continuously working towards developing 5+ Surgical Site Infections treatment therapies, analyzes DelveInsight.
Surgical Site Infections Overview:
A surgical site…
Synovial Sarcoma Clinical and Non-Clinical Studies, Key Companies, Therapeutic A …
Synovial Sarcoma Pipeline constitutes 15+ key companies continuously working towards developing 20+ Synovial Sarcoma treatment therapies, analyzes DelveInsight.
Synovial Sarcoma Overview:
Synovial sarcoma is a rare soft…
Peripheral T-Cell Lymphoma Treatment Market Size in 7MM is expected to grow at a …
DelveInsight's "Peripheral T-Cell Lymphoma Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of the Peripheral T-Cell Lymphoma, historical and forecasted epidemiology as…
